http://ijmspr.com/index.php/journal/issue/feed International Journal of Medical Sciences and Pharma Research 2024-09-15T03:51:55-04:00 Editor IJMSPR info.ijmspr@gmail.com Open Journal Systems <p>International Journal of Medical Sciences and Pharma Research is a <em>double-blind peer-reviewed Quarterly</em> <em>International </em>Journal dedicated to the publication of research papers, reviews, mini-reviews, Short communications and case studies. This publication is aimed at a broad, interdisciplinary audience of academic and industrial researchers actively engaged in basic and applied laboratory practice, related to dental &amp; health &amp; health sciences.</p> http://ijmspr.com/index.php/journal/article/view/106 Improving Cognitive Function: Blood Transfusions and Neurological Benefits in HIV Management 2024-08-02T10:50:32-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>HIV-associated neurocognitive disorders (HAND) continue to affect a significant number of individuals despite the widespread use of antiretroviral therapy (ART). This review explores the potential benefits of blood transfusions in improving cognitive function among HIV patients. Blood transfusions, primarily used to treat anemia, can enhance oxygen delivery to the brain, thereby ameliorating cognitive deficits. Anemia is a common comorbidity in HIV, and its correction through blood transfusions has been associated with improvements in attention, memory, and executive function. Beyond addressing anemia, blood transfusions may also offer neuroprotective effects by modulating systemic inflammation. Chronic inflammation, a hallmark of HIV infection, contributes significantly to neurocognitive decline. By reducing levels of pro-inflammatory cytokines, blood transfusions can potentially mitigate neuroinflammation and protect against neuronal damage. Clinical studies have shown that HIV patients receiving blood transfusions for anemia management exhibit slower cognitive decline, suggesting a broader role for transfusions in preserving neurological health. While promising, the use of blood transfusions in HIV management must be carefully considered due to associated risks such as transfusion reactions and iron overload.</p> <p><strong>Keywords</strong>: HIV, cognitive function, blood transfusions, neurological benefits, neurocognitive disorders</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/107 Improved Wound Healing: The Healing Power of Blood Transfusions for Individuals with HIV 2024-08-02T10:51:44-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Wound healing in individuals with HIV is often compromised due to impaired immune function, chronic inflammation, and common comorbidities like anemia. Blood transfusions, traditionally used to manage anemia, have shown promise in enhancing wound healing through multiple mechanisms. This review explores the role of blood transfusions in improving wound healing for HIV-positive patients, focusing on their impact on oxygen delivery, immune modulation, inflammation reduction, and tissue repair. By restoring adequate hemoglobin levels, blood transfusions can improve oxygenation, support cellular metabolism, and promote collagen synthesis and angiogenesis, all crucial for effective wound healing. In addition to addressing anemia, blood transfusions may offer broader benefits, including the modulation of immune responses and the reduction of systemic inflammation. These effects can create a more favorable environment for wound healing, helping to mitigate prolonged inflammation and tissue damage commonly seen in HIV-positive individuals. Clinical studies and case reports have highlighted significant improvements in wound healing outcomes following transfusion therapy, underscoring its potential as a complementary intervention in HIV care.</p> <p><strong>Keywords:</strong> anemia, blood transfusions, HIV, immune response, wound healing,</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/110 Mitigating the Impact of HIV on Organ Function: Blood Transfusions as a Therapeutic Strategy 2024-08-30T23:35:06-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>HIV (Human Immunodeficiency Virus) significantly impacts organ function, leading to various complications that can adversely affect the health and quality of life of individuals living with the virus. This review explores the multifaceted effects of HIV on organ systems, including the cardiovascular, renal, hepatic, and pulmonary functions, and highlights the potential of blood transfusions as a therapeutic strategy to mitigate these adverse effects. Blood transfusions can effectively address anemia—a common complication in HIV-positive individuals—enhancing oxygen delivery to tissues and improving overall organ function. Additionally, blood transfusions may exert immune-modulating effects, contributing to improved immune responses and potentially reducing the risk of opportunistic infections. This review discusses clinical evidence supporting the benefits of blood transfusions in enhancing organ function and quality of life among HIV-positive patients. Furthermore, it addresses the challenges and considerations associated with transfusion therapy, emphasizing the importance of individualized patient assessments and coordinated care strategies.</p> <p><strong>Keywords:</strong> anemia, blood transfusions, HIV, immune response, organ function</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/111 Reducing Hospitalization Rates: The Preventive Benefits of Blood Transfusions in HIV Care 2024-08-30T23:36:16-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Hospitalization rates among individuals living with HIV remain a significant challenge due to various complications, including opportunistic infections, anemia, and comorbidities. This review article explores the preventive benefits of blood transfusions as a strategic intervention in reducing hospitalization rates in HIV care. By correcting anemia, enhancing oxygen delivery, and improving overall health status, blood transfusions can play a vital role in preventing adverse health outcomes that often lead to hospitalization. We discuss the mechanisms through which transfusions provide these benefits, supported by clinical evidence and the implications for comprehensive HIV management. The role of blood transfusions extends beyond mere therapeutic intervention for severe anemia; they are increasingly recognized for their potential to improve patient outcomes and quality of life. By alleviating symptoms of anemia, enhancing organ function, and supporting immune responses, transfusions can contribute significantly to the health and well-being of individuals living with HIV. Clinical evidence indicates that timely blood transfusions can lead to fewer hospitalizations, better treatment outcomes, and overall improved health status.</p> <p><strong>Keywords: </strong>anemia, blood transfusions, HIV, hospitalization rates, preventive care</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/112 Preventing Complications in Children: Blood Transfusions in Pediatric HIV Management 2024-08-30T23:37:41-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Children living with HIV face unique challenges that significantly impact their health and development, with anemia being one of the most prevalent complications. Blood transfusions have emerged as a vital therapeutic intervention for managing anemia in pediatric HIV patients, providing immediate correction of hemoglobin levels and alleviating debilitating symptoms. This review explores the role of blood transfusions in preventing complications associated with HIV, emphasizing their importance in improving health outcomes and enhancing the quality of life for affected children. The mechanisms through which blood transfusions confer benefits include enhanced oxygen delivery to tissues, improved immune function, and support for growth and development. Clinical evidence highlights the effectiveness of transfusions in reducing hospitalization rates and promoting adherence to antiretroviral therapy (ART). Furthermore, integrating blood transfusions into comprehensive care models fosters a multidisciplinary approach that addresses the medical, nutritional, and psychosocial needs of pediatric patients, ensuring a holistic management strategy.</p> <p><strong>Keywords: </strong>Pediatrics, HIV, blood transfusions, anemia, immune function, HIV management</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/113 Addressing Sleep Disturbances: Blood Transfusions and Improved Sleep Patterns in HIV Patients 2024-08-30T23:38:48-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Sleep disturbances are prevalent among individuals living with HIV, significantly impacting their quality of life and overall health. This review explores the relationship between anemia, fatigue, and sleep quality in HIV patients, highlighting the potential role of blood transfusions as an effective intervention for mitigating sleep disturbances. Blood transfusions improve hemoglobin levels, enhance oxygen delivery, and alleviate fatigue, which may contribute to better sleep patterns in this population. The mechanisms through which blood transfusions can improve sleep quality include enhanced oxygenation, reduction of inflammation, and modulation of immune responses. By addressing anemia and its associated symptoms, blood transfusions may foster an environment conducive to restful sleep, ultimately supporting the physical and mental well-being of individuals living with HIV. Integrating blood transfusions into comprehensive HIV care strategies is crucial for optimizing health outcomes. A multidisciplinary approach that includes ongoing assessment and tailored interventions can help manage anemia, improve sleep quality, and enhance overall quality of life for patients.</p> <p><strong>Keywords:</strong> anemia, blood transfusions, fatigue, HIV, sleep disturbances, </p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/114 Improving Exercise Tolerance: Blood Transfusions and Physical Well-being in HIV Patients 2024-08-30T23:39:47-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Individuals living with HIV often experience reduced exercise tolerance due to anemia, fatigue, and muscle deconditioning, significantly impacting their quality of life. Blood transfusions emerge as a critical intervention to improve physical well-being by increasing hemoglobin levels and enhancing oxygen delivery to tissues. This review article explores the mechanisms by which blood transfusions positively influence exercise tolerance in HIV patients, highlighting the physiological benefits of improved oxygenation and energy levels, which facilitate greater participation in physical activities. In addition to the physiological benefits, enhanced exercise tolerance can lead to psychological improvements, reducing symptoms of anxiety and depression commonly faced by individuals with HIV. Engaging in physical activities fosters a sense of accomplishment and boosts self-esteem, creating a positive feedback loop that encourages a more active lifestyle. This multifaceted approach underscores the importance of integrating blood transfusion therapy into comprehensive HIV care to support both physical and mental health.</p> <p><strong>Keywords: </strong>anemia, blood transfusions, exercise tolerance, HIV, physical well-being</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/115 Reducing Viral Load Impact: Blood Transfusions as a Complementary Approach in HIV Treatment 2024-08-30T23:40:51-04:00 Emmanuel Ifeanyi Obeagu emmanuelobeagu@yahoo.com <p>Blood transfusions have traditionally been associated with the management of anemia in individuals living with HIV; however, their potential role as a complementary approach in reducing viral load impact is gaining attention. This review explores how blood transfusions can enhance immune function, improve oxygen delivery, and support the efficacy of antiretroviral therapy (ART), thereby contributing to better health outcomes for patients. By addressing complications associated with HIV, such as anemia and immune dysfunction, blood transfusions may play a crucial role in optimizing treatment strategies and enhancing the overall quality of life for individuals living with the virus. The relationship between viral load and immune function is critical in HIV management, as high viral loads are associated with increased morbidity and mortality. Blood transfusions can mitigate the negative effects of viral load by improving the physiological conditions necessary for an effective immune response. Enhanced oxygenation from transfusions supports immune cell proliferation and activity, potentially leading to better control of viral replication and lower viral load levels. Moreover, improving hemoglobin levels through transfusions can reduce fatigue, increase treatment adherence, and promote active participation in ART.</p> <p><strong>Keywords:</strong> anemia, blood transfusions, HIV, immune response, viral load</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Emmanuel Ifeanyi Obeagu http://ijmspr.com/index.php/journal/article/view/101 Pregnancy Related Medication Prescription Patterns 2024-07-20T00:15:27-04:00 Divya Amaravadi div4075@yahoo.com Sravya Guptha gudipatisravya2001@gmail.com Rama Rao Tadikonda tadikondarao7@gmail.com <p><strong>Introduction: </strong>Drug use during pregnancy presents significant challenges due to altered pharmacokinetics and pharmacodynamics, with potential adverse effects on the fetus. The USFDA (United States Food and Drug Administration) categorizes drugs from A to X based on their safety in pregnancy, guiding appropriate drug use. Hence, this research aimed to assess rationality in prescription pattern and to identify commonly prescribed medications in pregnant women.</p> <p><strong>Methodology:</strong> A pilot prospective observational study was conducted for three months at Gandhi Hospital, Secunderabad. Women of any gestational age willing to participate voluntarily were included in study while non-pregnancy cases and cases with incomplete data were excluded. Data collection focused on demographics, medical history, and prescribed medications. Prescription pattern was analyzed using WHO (<em>World Health Organization</em>) core prescribing indicators and USFDA pregnancy drug-risk categories.</p> <p><strong>Results</strong><strong>:</strong> Study highlighted the prevalence of anemia in 50% of pregnant women making it a possible factor for complications like premature birth and low birth weight if untreated. Majority of prescribed medications belong to Category B. Among 70 prescriptions, average number of drugs per prescription was 5.857 which was excess. Supplemental drug use accounted for 40.97% of the 410 prescription drugs, 168 drugs, and 242 drugs (59.024%) of the non-supplemental drugs prescribed.</p> <p><strong>Conclusion: </strong>Study emphasizes importance of supplemental drug use which was found to be deficient in the prescriptions. It is necessary for the well-being of mother and growth of fetus. Findings provide healthcare professionals with insights into current prescribing practices, aiming to enhance rational drug use in pregnancy.</p> <p><strong>Keywords</strong>: Pregnancy; USFDA drug risk category; prescription pattern.</p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Divya Amaravadi, Sravya Guptha , Rama Rao Tadikonda http://ijmspr.com/index.php/journal/article/view/108 The Relationship Between Compliance in Taking Anti Tuberculosis Drugs and the Results of Acid-Fast Bacteria (AFB) Examination as an Indicator of Recovery of TB Patients in Tanjung Pinang City in 2022-2023 2024-08-13T22:42:04-04:00 Diah Lestari diahtari1411@gmail.com Ida Hartati Lumban Tobing idahartatilumbantobing@gmail.com Husyain Djajaningrat husjain@gmail.com Fitria Kemalasari sarian1911@gmail.com <p>Tuberculosis (TB) is a chronic infectious disease caused by <em>Mycobacterium tuberculosis</em> with a treatment period of 6 to 8 months. <em>Mycobacterium tuberculosis</em> can become germ resistant or multidrug resistance (MDR) if you do not comply in taking anti-tuberculosis drugs (ATD), making this disease very difficult to cure. This research uses secondary data from the Tanjung Pinang City Population Control and Family Planning Health Service for 2022-2023. The aim is to determine the relationship between compliance in taking Anti-Tuberculosis Drugs (ATD) and the results of acid-fast bacteria <strong>(AFB)</strong> examinations of TB patients in Tanjung Pinang City. The research methodology was observational analytic using a <em>cross-sectional</em> design, with a total sampling technique from pulmonary TB patients with positive <strong>AFB</strong>, negative <strong>AFB</strong> with positive thorax and extrapulmonary, 252 TB patients. Data analysis used the <em>Fisher Exact</em> test with a confidence level of 95%. The results of data analysis showed that 91.3% of patients complied in taking drugs, and 87.3% recovered with negative <strong>AFB</strong> results. <em>Fisher Exact</em> analysis showed a significant difference in proportion between compliance in taking anti-tuberculosis drugs and the results of <strong>AFB</strong> examination of pulmonary TB patients with a <em>p-value</em> of 0.000 (p &lt; ∝0.05). The conclusion from this study is that there is a relationship between compliance in taking anti-tuberculosis drugs and the results of <strong>AFB</strong> examinations of pulmonary TB patients in Tanjung Pinang City in 2022-2023.</p> <p><strong>Keywords: </strong>Pulmonary TB, ATD, (AFB), <em>Ziehl Neelsen</em></p> 2024-09-15T00:00:00-04:00 Copyright (c) 2024 Diah Lestari, Ida Hartati Lumban Tobing, Husyain Djajaningrat, Fitria Kemalasari